國立虎尾科技大學 |

Optimizing Breast Cancer Management

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Optimizing Breast Cancer Management/ edited by William J. Gradishar.
其他作者:	Gradishar, William J.
面頁冊數:	V, 189 p. 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-70197-4
ISBN:	9783319701974

Optimizing Breast Cancer Management
Optimizing Breast Cancer Management[electronic resource] /edited by William J. Gradishar. - 1st ed. 2018. - V, 189 p. 11 illus. in color.online resource. - Cancer Treatment and Research,1730927-3042 ;. - Cancer Treatment and Research,165.

Strategies to maintain fertility in young breast cancer patients -- Sexual dysfuncton in breast cancer survivors -- The breast cancer screening conundrum -- New Imaging modalities in breast cancer -- Is DCIS over treated -- “Personalizing” Breast Radiation -- Management of the axilla in early stage breast cancer -- Management of the breast in denovo MBC -- Identification of genetic lesions in patients with strong family history and no BRCA Mutation -- Managing “testing expectations” in breast cancer survivors -- The role of bone strengthening agents in early and advanced disease -- Overcoming endocrine resistance -- Optimal Adjuvant endocrine therapy -- Choosing wisely in HER2 positive metastatic breast cancer -- Should early stage, triple negative breast cancer be treated with preoperative systemic therapy?

This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. In closing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance.

ISBN: 9783319701974

Standard No.: 10.1007/978-3-319-70197-4doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Optimizing Breast Cancer Management
LDR:03387nam a22004095i 4500 001 997617
003 DE-He213
005 20200703231520.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319701974 $9 978-3-319-70197-4
024 7 $a 10.1007/978-3-319-70197-4 $2 doi
035 $a 978-3-319-70197-4
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Optimizing Breast Cancer Management $h [electronic resource] / $c edited by William J. Gradishar.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a V, 189 p. 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Treatment and Research, $x 0927-3042 ; $v 173
505 0 $a Strategies to maintain fertility in young breast cancer patients -- Sexual dysfuncton in breast cancer survivors -- The breast cancer screening conundrum -- New Imaging modalities in breast cancer -- Is DCIS over treated -- “Personalizing” Breast Radiation -- Management of the axilla in early stage breast cancer -- Management of the breast in denovo MBC -- Identification of genetic lesions in patients with strong family history and no BRCA Mutation -- Managing “testing expectations” in breast cancer survivors -- The role of bone strengthening agents in early and advanced disease -- Overcoming endocrine resistance -- Optimal Adjuvant endocrine therapy -- Choosing wisely in HER2 positive metastatic breast cancer -- Should early stage, triple negative breast cancer be treated with preoperative systemic therapy?
520 $a This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. In closing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance.
650 0 $a Oncology . $3 1253469
650 0 $a Gynecology . $3 1253939
650 0 $a Radiotherapy. $3 593952
650 1 4 $a Oncology. $3 593951
650 2 4 $a Gynecology. $3 644094
700 1 $a Gradishar, William J. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 678244
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319701950
776 0 8 $i Printed edition: $z 9783319701967
776 0 8 $i Printed edition: $z 9783319889016
830 0 $a Cancer Treatment and Research, $x 0927-3042 ; $v 165 $3 1254896
856 4 0 $u https://doi.org/10.1007/978-3-319-70197-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)